More on QURE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $22.43 |
|
|||
| Open | $22.50 | ||||
| 52 Wk High | $22.79 | ||||
| 52 Wk Low | $6.63 | ||||
| Day High | $22.61 | ||||
| Day Low | $21.57 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 770,108 | ||||
- Form SCHEDULE 13G/A uniQure N.V. Filed by: JPMORGAN CHASE & CO
- uniQure BV (QURE) PT Raised to $48 at UBS
- Barclays Downgrades uniQure BV (QURE) to Equalweight
- uniQure BV (QURE) PT Lowered to $48 at RBC Capital
- H.C. Wainwright Reiterates Buy Rating on uniQure BV (QURE)
- uniQure BV (QURE) PT Lowered to $31 at Goldman Sachs
- QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
- Form 8-K uniQure N.V. For: Sep 29
- Stifel Reiterates Buy Rating on uniQure BV (QURE)
- uniQure plunges 65% as 48-month Huntington’s gene therapy data misses key stat
Entities mentioned with QURE
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Chardan Capital Markets | View Related Stories »
- Show More...
